fertility

Product Purpose

• Hormonal Stimulation:
  • Men: Single doses of kisspeptin-10 (0.01–3 nmol/kg IV) increased LH by ~2–5-fold and testosterone by ~20–30% within 2–4 hours in healthy men (Dhillo et al., 2005). Subcutaneous doses (0.1–10 µg/kg) sustained LH/FSH release over 24 hours.
  • Women: Enhanced LH/FSH surges in premenopausal women, supporting ovulation in infertility studies (Jayasena et al., 2014).
• Fertility:
  • Improved ovulation rates in women with hypothalamic amenorrhea, with ~60% achieving follicular maturation at 10 µg/kg twice daily for 2 weeks (Jayasena et al., 2010).
  • Enhanced sperm parameters in hypogonadal men, with potential for male infertility treatment.
• Muscle Growth (Indirect):
  • Testosterone elevation promotes protein synthesis and muscle hypertrophy, with anecdotal reports of 0.5–1 kg lean mass gain in 8–12 weeks when combined with resistance training, though direct anabolic effects are weaker than SARMs or steroids.
• Weight Gain (Indirect):
  • Testosterone’s anabolic effects support lean mass gain (~0.5–1.5 kg in 12 weeks) in hypogonadal men, with minimal fat accumulation. Appetite may increase mildly via testosterone’s metabolic effects, but kisspeptin lacks direct ghrelin-like hunger stimulation.
• Other Benefits:
  • Mood and Libido: Improves sexual motivation and mood via dopamine and testosterone pathways, enhancing quality of life.
  • Bone Health: Supports bone density via testosterone/estrogen, relevant for hypogonadism or osteoporosis research.
  • Metabolic Health: Improves insulin sensitivity and glucose metabolism in preclinical models, with potential for type 2 diabetes research.

Research Use Only

Kisspeptin is intended strictly for in vitro testing and laboratory experimentation. It’s not intended for human or animal medical use. It’s not a drug, food, or cosmetic and should not be misbranded, misused, or mislabeled as such.